ASS1 and hepatocellular carcinoma: The current investigation was initiated to elucidate the relationship between ASS1 protein expression, ADI-PEG 20 sensitivity and cisplatin resistance, as well as to assess ASS1 regulation in response to cisplatin and in combination with ADI-PEG 20 in HCC.